Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asacol once-daily versus three-times-daily maintenance study in ulcerative colitis
2005-002784-91Phase 3Completed
- Sponsor
- Cardiff and Vale University Health Board
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Salcrozine in autoimmune colitis (2 arms), sponsored by Cardiff and Vale University Health Board. Started Nov 2005; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2005-002784-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002784-91.